Can immune cells predict CART success in myeloma?
NCT ID NCT07180992
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 37 times
Summary
This study looks at how certain immune cells (monocytes) influence the response to CART cell therapy in people with multiple myeloma. Researchers will analyze blood samples before and after treatment to find factors that predict better outcomes. The goal is to improve understanding of why some patients relapse early. About 25 adults with multiple myeloma who are scheduled for CART therapy will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU Amiens
RECRUITINGAmiens, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.